|
2024-11-14 |
2024-11-13 |
S
Sale
|
ORDAN MARK S
Non-Executive Director
|
27,600
-16.6%
15.35
USD 423,660
|
27,600
-16.6%
|
15.35
|
USD 423,660
|
|
|
2024-11-12 |
2024-11-08 |
S
Sale
|
Moore Mary Ann E
EVP, GC, Chief Admin Off & Sec
Officer
|
8,108
-5.6%
16.00
USD 129,728
|
8,108
-5.6%
|
16.00
|
USD 129,728
|
|
|
2024-09-03 |
2024-08-30 |
S
Sale
|
Swift James D
Chief Executive Officer
Executive Director
|
11,100
-6.1%
10.79
USD 119,769
|
11,100
-6.1%
|
10.79
|
USD 119,769
|
|
|
2024-08-29 |
2024-08-27 |
S
Sale
|
Linynsky Laura A
Non-Executive Director
|
7,000
-18.5%
11.16
USD 78,120
|
7,000
-18.5%
|
11.16
|
USD 78,120
|
|
|
2024-08-13 |
2024-08-12 |
S
Sale
|
Richards C Marc
EVP, Chief Financial Officer
Officer
|
17,438
-9.0%
10.08
USD 175,775
|
17,438
-9.0%
|
10.08
|
USD 175,775
|
|
|
2024-08-13 |
2024-08-09 |
S
Sale
|
Richards C Marc
EVP, Chief Financial Officer
Officer
|
32,562
-14.4%
10.08
USD 328,225
|
32,562
-14.4%
|
10.08
|
USD 328,225
|
|
|
2023-12-15 |
2023-12-14 |
S
Sale
|
Swift James D
Chief Executive Officer
Executive Director
|
5,764
-6.0%
9.58
USD 55,219
|
5,764
-6.0%
|
9.58
|
USD 55,219
|
|
|
2023-12-15 |
2023-12-14 |
S
Sale
|
Moore Mary Ann E
EVP, General Counsel & Sec
Officer
|
970
-1.2%
9.62
USD 9,331
|
970
-1.2%
|
9.62
|
USD 9,331
|
|
|
2023-12-15 |
2023-12-14 |
S
Sale
|
Moore Mary Ann E
EVP, General Counsel & Sec
Officer
|
1,150
-6.8%
9.62
USD 11,063
|
1,150
-6.8%
|
9.62
|
USD 11,063
|
|
|
2023-06-16 |
2023-06-14 |
S
Sale
|
Swift James D
Chief Executive Officer
Executive Director
|
13,193
-12.0%
14.14
USD 186,549
|
13,193
-12.0%
|
14.14
|
USD 186,549
|
|
|
2023-05-26 |
2023-05-25 |
S
Sale
|
ORDAN MARK S
Non-Executive Director
|
33,000
-18.2%
13.26
USD 437,580
|
33,000
-18.2%
|
13.26
|
USD 437,580
|
|
|
2023-05-22 |
2023-05-19 |
S
Sale
|
Weis Shirley A
Non-Executive Director
|
1,007
-5.4%
13.63
USD 13,725
|
1,007
-5.4%
|
13.63
|
USD 13,725
|
|
|
2023-05-22 |
2023-05-18 |
S
Sale
|
Weis Shirley A
Non-Executive Director
|
17,993
-49.1%
13.55
USD 243,805
|
17,993
-49.1%
|
13.55
|
USD 243,805
|
|
|
2022-11-23 |
2022-11-21 |
S
Sale
|
ORDAN MARK S
Chief Executive Officer
Executive Director
|
22,166
-6.0%
15.45
USD 342,465
|
22,166
-6.0%
|
15.45
|
USD 342,465
|
|
|
2022-11-09 |
2022-11-07 |
S
Sale
|
Swift James D
EVP, Chief Operating Officer
Officer
|
24,000
-21.4%
15.31
USD 367,440
|
24,000
-21.4%
|
15.31
|
USD 367,440
|
|
|
2022-01-11 |
2022-01-11 |
PS
Planned sale
|
MEDEL ROGER MD
Non-Executive Director
|
40,107
-5.1%
26.58
USD 1,066,044
|
40,107
-5.1%
|
26.58
|
USD 1,066,044
|
|
|
2022-01-11 |
2022-01-10 |
PS
Planned sale
|
MEDEL ROGER MD
Non-Executive Director
|
59,893
-7.1%
26.44
USD 1,583,571
|
59,893
-7.1%
|
26.44
|
USD 1,583,571
|
|
|
2022-01-07 |
2022-01-05 |
PS
Planned sale
|
MEDEL ROGER MD
Non-Executive Director
|
12,639
-1.5%
27.42
USD 346,561
|
12,639
-1.5%
|
27.42
|
USD 346,561
|
|
|
2022-01-04 |
2022-01-04 |
PS
Planned sale
|
MEDEL ROGER MD
Non-Executive Director
|
87,361
-9.3%
27.43
USD 2,396,312
|
87,361
-9.3%
|
27.43
|
USD 2,396,312
|
|
|
2022-01-04 |
2021-12-31 |
PS
Planned sale
|
MEDEL ROGER MD
Non-Executive Director
|
6,564
-0.7%
27.16
USD 178,278
|
6,564
-0.7%
|
27.16
|
USD 178,278
|
|
|
2021-11-10 |
2021-11-10 |
PS
Planned sale
|
Pepia John C
Principal Accounting Officer
Officer
|
5,000
-4.9%
28.45
USD 142,250
|
5,000
-4.9%
|
28.45
|
USD 142,250
|
|
|
2021-11-10 |
2021-11-10 |
PS
Planned sale
|
Hinson Roger Mack
Pres., PDX & OBX Medical Group
Officer
|
8,800
-7.6%
28.38
USD 249,744
|
8,800
-7.6%
|
28.38
|
USD 249,744
|
|
|
2021-10-29 |
2021-10-29 |
PS
Planned sale
|
Pepia John C
Principal Accounting Officer
Officer
|
9,238
-8.3%
26.87
USD 248,225
|
9,238
-8.3%
|
26.87
|
USD 248,225
|
|
|
2021-10-29 |
2021-10-28 |
PS
Planned sale
|
MEDEL ROGER MD
Non-Executive Director
|
10,387
-0.9%
29.00
USD 301,223
|
10,387
-0.9%
|
29.00
|
USD 301,223
|
|
|
2021-10-06 |
2021-10-04 |
PS
Planned sale
|
MEDEL ROGER MD
Non-Executive Director
|
1,270
-0.1%
29.00
USD 36,830
|
1,270
-0.1%
|
29.00
|
USD 36,830
|
|
|
2021-08-11 |
2021-08-10 |
PS
Planned sale
|
Hinson Roger Mack
Pres., PDX & OBX Medical Group
Officer
|
8,799
-7.0%
32.35
USD 284,648
|
8,799
-7.0%
|
32.35
|
USD 284,648
|
|
|
2021-04-02 |
2021-04-01 |
PS
Planned sale
|
MEDEL ROGER MD
Non-Executive Director
|
782
-0.1%
25.81
USD 20,183
|
782
-0.1%
|
25.81
|
USD 20,183
|
|
|
2021-04-02 |
2021-04-01 |
PS
Planned sale
|
MEDEL ROGER MD
Non-Executive Director
|
99,218
-7.0%
25.40
USD 2,520,137
|
99,218
-7.0%
|
25.40
|
USD 2,520,137
|
|
|
2021-01-05 |
2021-01-04 |
PS
Planned sale
|
MEDEL ROGER MD
Non-Executive Director
|
52,961
-3.4%
23.89
USD 1,265,238
|
52,961
-3.4%
|
23.89
|
USD 1,265,238
|
|
|
2021-01-05 |
2021-01-04 |
PS
Planned sale
|
MEDEL ROGER MD
Non-Executive Director
|
47,039
-3.0%
23.41
USD 1,101,183
|
47,039
-3.0%
|
23.41
|
USD 1,101,183
|
|
|
2020-12-11 |
2020-12-10 |
PS
Planned sale
|
MEDEL ROGER MD
Non-Executive Director
|
33,194
-2.0%
23.04
USD 764,919
|
33,194
-2.0%
|
23.04
|
USD 764,919
|
|
|
2020-12-11 |
2020-12-09 |
PS
Planned sale
|
MEDEL ROGER MD
Non-Executive Director
|
66,806
-4.0%
23.00
USD 1,536,672
|
66,806
-4.0%
|
23.00
|
USD 1,536,672
|
|
|
2020-09-17 |
2020-09-15 |
S
Sale
|
Andreano Dominic J
EVP, General Counsel and Secy
Officer
|
22,000
-29.1%
18.93
USD 416,425
|
22,000
-29.1%
|
18.93
|
USD 416,425
|
|
|
2020-09-17 |
2020-09-15 |
S
Sale
|
Nikolopoulos Nicholas J
EVP Chf Strategy & Growth Offi
Officer
|
10,000
-12.2%
19.02
USD 190,179
|
10,000
-12.2%
|
19.02
|
USD 190,179
|
|
|
2019-11-01 |
2019-11-01 |
PS
Planned sale
|
Goldschmidt, MD Pascal J
|
5,000
-31.6%
22.88
USD 114,403
|
5,000
-31.6%
|
22.88
|
USD 114,403
|
|
|
2019-09-04 |
2019-09-03 |
PS
Planned sale
|
Goldschmidt, MD Pascal J
|
5,000
-24.0%
20.81
USD 104,050
|
5,000
-24.0%
|
20.81
|
USD 104,050
|
|
|
2019-08-13 |
2019-08-12 |
B
Purchase
|
FERNANDEZ MICHAEL
Non-Executive Director
|
61,204
+32.4%
21.35
USD 1,306,816
|
61,204
+32.4%
|
21.35
|
USD 1,306,816
|
|
|
2019-08-13 |
2019-08-12 |
B
Purchase
|
FERNANDEZ MICHAEL
Non-Executive Director
|
61,205
+21.2%
21.35
USD 1,306,837
|
61,205
+21.2%
|
21.35
|
USD 1,306,837
|
|
|
2019-08-12 |
2019-08-09 |
B
Purchase
|
FERNANDEZ MICHAEL
Non-Executive Director
|
124,553
+193.9%
21.52
USD 2,680,879
|
124,553
+193.9%
|
21.52
|
USD 2,680,879
|
|
|
2019-08-12 |
2019-08-09 |
B
Purchase
|
FERNANDEZ MICHAEL
Non-Executive Director
|
124,553
+75.7%
21.52
USD 2,680,879
|
124,553
+75.7%
|
21.52
|
USD 2,680,879
|
|
|
2019-08-12 |
2019-08-08 |
B
Purchase
|
FERNANDEZ MICHAEL
Non-Executive Director
|
64,243
+inf%
21.68
USD 1,392,596
|
64,243
+inf%
|
21.68
|
USD 1,392,596
|
|
|
2019-08-12 |
2019-08-08 |
B
Purchase
|
FERNANDEZ MICHAEL
Non-Executive Director
|
64,242
+64.1%
21.68
USD 1,392,574
|
64,242
+64.1%
|
21.68
|
USD 1,392,574
|
|
|
2019-03-15 |
2019-03-13 |
S
Sale
|
Goldschmidt, MD Pascal J
Non-Executive Director
|
3,300
-13.7%
30.40
USD 100,331
|
3,300
-13.7%
|
30.40
|
USD 100,331
|
|
|
2019-03-08 |
2019-03-07 |
PS
Planned sale
|
Andreano Dominic J
SVP, General Counsel and Secy
|
4,608
-6.7%
30.16
USD 138,984
|
4,608
-6.7%
|
30.16
|
USD 138,984
|
|
|
2019-03-01 |
2019-03-01 |
PS
Planned sale
|
CALABRO JOSEPH M
President
Officer
|
12,130
-2.7%
32.91
USD 399,197
|
12,130
-2.7%
|
32.91
|
USD 399,197
|
|
|
2019-03-01 |
2019-03-01 |
PS
Planned sale
|
Clark David A.
Chief Operating Officer
Officer
|
6,452
-4.5%
32.90
USD 212,262
|
6,452
-4.5%
|
32.90
|
USD 212,262
|
|
|
2019-02-22 |
2019-02-20 |
PS
Planned sale
|
Andreano Dominic J
SVP, General Counsel and Secy
Officer
|
1,289
-1.8%
36.22
USD 46,690
|
1,289
-1.8%
|
36.22
|
USD 46,690
|
|
|
2019-01-23 |
2019-01-22 |
PS
Planned sale
|
Pepia John C
Principal Accounting Officer
Officer
|
2,500
-8.0%
36.60
USD 91,500
|
2,500
-8.0%
|
36.60
|
USD 91,500
|
|
|
2018-08-15 |
2018-08-14 |
S
Sale
|
Pepia John C
Principal Accounting Officer
Officer
|
1,025
-3.6%
48.20
USD 49,405
|
1,025
-3.6%
|
48.20
|
USD 49,405
|
|
|
2018-08-15 |
2018-08-14 |
S
Sale
|
Pepia John C
Principal Accounting Officer
Officer
|
1,540
-5.1%
48.18
USD 74,197
|
1,540
-5.1%
|
48.18
|
USD 74,197
|
|
|
2018-08-15 |
2018-08-14 |
S
Sale
|
Pepia John C
Principal Accounting Officer
Officer
|
935
-3.0%
48.17
USD 45,039
|
935
-3.0%
|
48.17
|
USD 45,039
|
|
|
2018-06-13 |
2018-06-12 |
S
Sale
|
Lopez-Blanco Vivian
Chief Financial Officer
Officer
|
13,942
-12.2%
46.46
USD 647,775
|
13,942
-12.2%
|
46.46
|
USD 647,775
|
|
|
2018-06-13 |
2018-06-12 |
PS
Planned sale
|
Pepia John C
Principal Accounting Officer
Officer
|
6,516
-17.3%
46.56
USD 303,374
|
6,516
-17.3%
|
46.56
|
USD 303,374
|
|
|
2018-06-13 |
2018-06-11 |
S
Sale
|
Andreano Dominic J
SVP, General Counsel and Secy
Officer
|
18,000
-42.0%
46.95
USD 845,059
|
18,000
-42.0%
|
46.95
|
USD 845,059
|
|
|
2018-06-01 |
2018-06-01 |
PS
Planned sale
|
Clark David A.
Pres. Mednax Natl Med Group
Officer
|
11,607
-26.1%
45.15
USD 524,096
|
11,607
-26.1%
|
45.15
|
USD 524,096
|
|
|
2018-06-01 |
2018-06-01 |
S
Sale
|
CALABRO JOSEPH M
President and COO
|
22,186
-6.3%
45.20
USD 1,002,738
|
22,186
-6.3%
|
45.20
|
USD 1,002,738
|
|
|
2018-05-23 |
2018-05-22 |
S
Sale
|
Pepia John C
Principal Accounting Officer
Officer
|
3,000
-7.6%
46.43
USD 139,290
|
3,000
-7.6%
|
46.43
|
USD 139,290
|
|
|
2018-03-14 |
2018-03-13 |
S
Sale
|
Pepia John C
Principal Accounting Officer
|
3,000
-7.6%
58.35
USD 175,063
|
3,000
-7.6%
|
58.35
|
USD 175,063
|
|
|
2017-12-12 |
2017-12-12 |
S
Sale
|
Pepia John C
Principal Accounting Officer
|
3,000
-8.4%
51.58
USD 154,740
|
3,000
-8.4%
|
51.58
|
USD 154,740
|
|
|
2017-11-03 |
2017-11-03 |
S
Sale
|
ALVAREZ CESAR L
|
10,668
-24.1%
42.59
USD 454,375
|
10,668
-24.1%
|
42.59
|
USD 454,375
|
|
|
2017-09-13 |
2017-09-12 |
S
Sale
|
Pepia John C
Principal Accounting Officer
|
3,000
-8.4%
42.85
USD 128,550
|
3,000
-8.4%
|
42.85
|
USD 128,550
|
|
|
2017-06-14 |
2017-06-14 |
S
Sale
|
Goldschmidt, MD Pascal J
|
1,969
-9.8%
57.57
USD 113,355
|
1,969
-9.8%
|
57.57
|
USD 113,355
|
|
|
2017-06-02 |
2017-06-01 |
PS
Planned sale
|
CALABRO JOSEPH M
President and COO
|
23,327
-8.2%
55.00
USD 1,282,934
|
23,327
-8.2%
|
55.00
|
USD 1,282,934
|
|
|
2017-06-02 |
2017-06-01 |
PS
Planned sale
|
Clark David A.
Pres. Mednax Natl Med Group
|
10,202
-28.9%
54.99
USD 561,041
|
10,202
-28.9%
|
54.99
|
USD 561,041
|
|
|
2017-05-08 |
2017-05-05 |
S
Sale
|
Lopez-Blanco Vivian
Chief Financial Officer
Officer
|
7,778
-13.2%
55.82
USD 434,183
|
7,778
-13.2%
|
55.82
|
USD 434,183
|
|
|
2017-05-08 |
2017-05-05 |
B
Purchase
|
Kadre Manuel
Non-Executive Director
|
21,704
+24.2%
55.79
USD 1,210,838
|
21,704
+24.2%
|
55.79
|
USD 1,210,838
|
|
|
2017-03-17 |
2017-03-15 |
S
Sale
|
Andreano Dominic J
SVP, General Counsel and Secy
|
6,517
-26.3%
70.84
USD 461,645
|
6,517
-26.3%
|
70.84
|
USD 461,645
|
|
|
2017-02-24 |
2017-02-23 |
S
Sale
|
SOSA ENRIQUE
Non-Executive Director
|
10,668
-48.7%
69.65
USD 743,060
|
10,668
-48.7%
|
69.65
|
USD 743,060
|
|
|
2017-02-17 |
2017-02-17 |
S
Sale
|
Lopez-Blanco Vivian
Chief Financial Officer
|
15,164
-20.4%
70.01
USD 1,061,606
|
15,164
-20.4%
|
70.01
|
USD 1,061,606
|
|
|
2017-02-17 |
2017-02-16 |
S
Sale
|
Andreano Dominic J
SVP, General Counsel and Secy
|
6,000
-19.5%
69.59
USD 417,531
|
6,000
-19.5%
|
69.59
|
USD 417,531
|
|
|
2017-02-17 |
2017-02-16 |
PS
Planned sale
|
Pepia John C
Principal Accounting Officer
|
1,500
-5.0%
69.58
USD 104,372
|
1,500
-5.0%
|
69.58
|
USD 104,372
|
|
|
2017-02-17 |
2017-02-16 |
S
Sale
|
Pepia John C
Principal Accounting Officer
|
1,000
-3.2%
69.58
USD 69,581
|
1,000
-3.2%
|
69.58
|
USD 69,581
|
|
|
2017-02-17 |
2017-02-16 |
S
Sale
|
GABOS PAUL G
Non-Executive Director
|
21,336
-65.5%
69.63
USD 1,485,664
|
21,336
-65.5%
|
69.63
|
USD 1,485,664
|
|
|
2017-02-13 |
2017-02-10 |
S
Sale
|
Goldschmidt, MD Pascal J
|
25,294
-58.8%
67.82
USD 1,715,318
|
25,294
-58.8%
|
67.82
|
USD 1,715,318
|
|
|
2017-02-10 |
2017-02-09 |
S
Sale
|
WALDEMAR, MD CARLO A
Non-Executive Director
|
5,334
-32.2%
67.90
USD 362,186
|
5,334
-32.2%
|
67.90
|
USD 362,186
|
|
